Read + Share
Lamb D, De Sousa D, Quast K, Fundel-Clemens K, et al. RORgammat inhibitors block both IL-17 and IL-22 conferring a potential advantage
over anti-IL-17 alone to treat severe asthma. Respir Res 2021;22:158.
PMID: 34022896
|
 |
|
Lamb D, De Sousa D, Quast K, Fundel-Clemens K, et al. RORgammat inhibitors block both IL-17 and IL-22 conferring a potential advantage
over anti-IL-17 alone to treat severe asthma. Respir Res 2021;22:158.
PMID: 34022896
|
|
|
|